Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasm Metastasis × pixantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 3 Recurrence 2 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pembrolizumab 83 Gemcitabine 63 Paclitaxel 51 Docetaxel 46 Carboplatin 44 Nivolumab 36 Cisplatin 34 Capecitabine 33 Pemetrexed 30 Fluorouracil 29 Bevacizumab 28 Cetuximab 26 Trastuzumab 24 130-nm albumin-bound paclitaxel 24 Albumin-Bound Paclitaxel 22 Irinotecan 21 Leucovorin 18 Fulvestrant 18 Panitumumab 16 Oxaliplatin 16 abemaciclib 14 Letrozole 12 Ipilimumab 12 Drug Therapy 12 palbociclib 11 cemiplimab 11 atezolizumab 11 Lapatinib 11 Doxorubicin 11 vandetanib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01632436 2023-10-02

Hepatic

CTI BioPharma

Phase 1 Withdrawn

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡